Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 326

JOINT STATEMENT of counsel on Mediation Issues. (Rich, Patricia)

Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Doc. 326

Case 1:05-cv-12237-WGY

Document 326

Filed 03/20/2007

Page 1 of 5

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS ____________________________________ ) AMGEN INC., ) ) Plaintiff, ) ) v. ) ) F. HOFFMANN-LAROCHE ) LTD., a Swiss Company, ROCHE ) DIAGNOSTICS GmbH, a German ) Company and HOFFMANN LAROCHE ) INC., a New Jersey Corporation, ) ) Defendants. ) ____________________________________)

C.A. NO.: 05-12237-WGY

JOINT REPORT ON MEDIATION ISSUES Pursuant to the February 25, 2007 Order from Magistrate Judge Robert B. Collings, Amgen Inc. ("Amgen") and F. Hoffmann-LaRoche Ltd., Roche Diagnostics GmbH, and Hoffmann LaRoche Inc., (collectively "Roche") file this Joint Report on Mediation Issues: 1. Timing of Mediation: A. Amgen's position: Amgen believes that in order for a mediation to

have any potential of being successful, it must occur after Roche's scheduled Prescription Drug User Fee Amendments ("PDUFA") date, which Roche and the Federal Drug Administration ("FDA") have agreed to postpone from February 20, 2007 until May 20, 2007. In addition, the parties' motions for summary judgment are due on May 18, 2007, and it would be beneficial for the parties, and the mediator, to have the benefit of this briefing to assess the relative strengths and weaknesses of the case. Accordingly, it is Amgen's position that the mediation be scheduled after May 20, 2007.

DM1\1079349.1

Dockets.Justia.com

Case 1:05-cv-12237-WGY

Document 326

Filed 03/20/2007

Page 2 of 5

B.

Roche's position: In light of the Court's direction to address the

mediation as promptly as possible, it is Roche's position that the mediation be scheduled in April. 2. Duration of Mediation: A. Amgen's position: Amgen believes the Court should set aside four

hours for the mediation. B. Roche's position: Roche is agreeable to a mediation of four hours, but

believes that a full day mediation might be more productive. 3. Location of Mediation: The parties agree the mediation should take place in

Boston, Massachusetts.

2
DM1\1079349.1

Case 1:05-cv-12237-WGY

Document 326

Filed 03/20/2007

Page 3 of 5

Dated: March 20, 2007

Respectfully Submitted, AMGEN INC., By its attorneys,

Of Counsel: Stuart L. Watt Wendy A. Whiteford Monique L. Cordray Darrell G. Dotson Kimberlin L. Morley AMGEN INC. One Amgen Center Drive Thousand Oaks, CA 91320-1789 [phone]

/s/ Patricia R. Rich D. Dennis Allegretti (BBO#545511) Michael R. Gottfried (BBO# 542156) Patricia R. Rich (BBO# 640578) DUANE MORRIS LLP 470 Atlantic Avenue, Suite 500 Boston, MA 02210 Telephone: [phone] Facsimile: [phone] Lloyd R. Day, Jr. DAY CASEBEER, MADRID & BATCHELDER LLP 20300 Stevens Creek Boulevard, Suite 400 Cupertino, CA 95014 Telephone: [phone] Facsimile: [phone] William Gaede III McDERMOTT WILL & EMERY 3150 Porter Drive Palo Alto, CA 94304 Telephone: [phone] Facsimile: [phone] Michael F. Borun Kevin M. Flowers MARSHALL, GERSTEIN & BORUN LLP 233 South Wacker Drive 6300 Sears Tower Chicago, IL 60606 Telephone: [phone] Facsimile: [phone]

3
DM1\1079349.1

Case 1:05-cv-12237-WGY

Document 326

Filed 03/20/2007

Page 4 of 5

F. HOFFMANN-LA ROCHE LTD, ROCHE DIAGNOSTICS GMBH, and HOFFMANN-LA ROCHE INC. By its Attorneys /s/ Julia Huston (by PRR with permission) Lee Carl Bromberg (BBO# 058480) Julia Huston (BBO# 562160) Keith E. Toms (BBO# 663369) Nicole A. Rizzo (BBO# 663853) BROMBERG & SUNSTEIN LLP 125 Summer Street Boston, MA 02110 Tel. [phone] [e-mail] Leora Ben-Ami (pro hac vice) Mark S. Popofsky (pro hac vice) Patricia A. Carson (pro hac vice) Thomas F. Fleming (pro hac vice) Howard S. Suh (pro hac vice) Peter Fratangelo (BBO# 639775) Vladimir Drozdoff (pro hac vice) David L. Cousineau (pro hac vice) KAYE SCHOLER LLP 425 Park Avenue New York, New York 10022 Tel. [phone]

4
DM1\1079349.1

Case 1:05-cv-12237-WGY

Document 326

Filed 03/20/2007

Page 5 of 5

CERTIFICATE OF SERVICE I hereby certify that this document, filed through the ECF system will be sent electronically to the registered participants as identified on the Notice of electronic filing and paper copies will be sent to those indicated as non-registered participants on March 20, 2007. /s/ Patricia R. Rich Patricia R. Rich

5
DM1\1079349.1